KT-362

N/A

Report date: 2022/02/18 16:05:17
NME

Base Information

Drug NameKT-362
Drug Alias NameKT-362
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersSodium channel alpha subunit blockersVoltage-gated calcium channel blockers +[4] 
TargetsPotassium channelSodium channel alpha subunitVoltage-gated calcium channel +[4] 
Therapy Area/IndicationsHypertensionCoronary DiseaseArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKotobuki
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKotobuki
Active IndicationsN/A
Inactive IndicationsHypertensionCoronary DiseaseArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A